MENU
+Compare
HROW
Stock ticker: NASDAQ
AS OF
Dec 3, 04:59 PM (EDT)
Price
$44.52
Change
+$4.35 (+10.83%)
Capitalization
1.47B

HROW Harrow Forecast, Technical & Fundamental Analysis

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U... Show more

HROW
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for HROW with price predictions
Nov 28, 2025

HROW in +1.85% Uptrend, rising for three consecutive days on November 28, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HROW advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HROW's RSI Indicator exited the oversold zone, of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on HROW as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HROW just turned positive on November 12, 2025. Looking at past instances where HROW's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

HROW moved above its 50-day moving average on November 25, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HROW declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HROW broke above its upper Bollinger Band on November 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for HROW entered a downward trend on November 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HROW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (31.348) is normal, around the industry mean (17.312). P/E Ratio (0.000) is within average values for comparable stocks, (72.847). HROW's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.956). HROW has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (5.790) is also within normal values, averaging (55.504).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
HROW
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

HROW is expected to report earnings to rise 40.15% to 46 cents per share on March 25

Harrow HROW Stock Earnings Reports
Q4'25
Est.
$0.46
Q3'25
Beat
by $0.09
Q2'25
Beat
by $0.23
Q1'25
Missed
by $0.56
Q4'24
Beat
by $0.11
The last earnings report on November 10 showed earnings per share of 33 cents, beating the estimate of 23 cents. With 471.75K shares outstanding, the current market capitalization sits at 1.47B.
A.I. Advisor
published General Information

General Information

a pharmaceutical company

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
102 Woodmont Boulevard
Phone
+1 615 733-4730
Employees
315
Web
https://www.harrow.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVFCX4.46N/A
N/A
Federated Hermes Intl Strat Val Div C
MIGFX45.83N/A
N/A
MFS Massachusetts Inv Gr Stk A
SSDCX25.49N/A
N/A
DWS Small Cap Growth C
FEBRX15.75N/A
N/A
First Eagle Global Income Builder R6
KNGIX11.55N/A
N/A
Vest S&P500 Div Aristocrats Trgt Inc Ins

HROW and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with OGI. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
+0.98%
OGI - HROW
37%
Loosely correlated
+0.64%
TKNO - HROW
33%
Loosely correlated
-5.36%
VTRS - HROW
33%
Poorly correlated
+0.09%
ELAN - HROW
33%
Poorly correlated
-0.53%
AMRX - HROW
32%
Poorly correlated
-2.48%
More

Groups containing HROW

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
+0.98%
Pharmaceuticals: Generic
industry (213 stocks)
42%
Loosely correlated
+0.76%